Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T14:30:29.363Z Has data issue: false hasContentIssue false
  • English
  • Français

SWN (subjective well-being under neuroleptics) in clinical practice

Published online by Cambridge University Press:  16 April 2020

P. Zeppegno ,
P. Prosperini ,
O. Allera ,
M. Colombo ,
A. Lombardi ,
S. Gili  and
E. Torre
P. Zeppegno
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
P. Prosperini
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
O. Allera
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
M. Colombo
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
A. Lombardi
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
S. Gili
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
E. Torre
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

To assess the use of SWN in the acute phase of psychiatric disease as a predictor of clinical outcome.

Methods

This study started in June 2009 and at the moment we have recruited 150 patients. The patients were divided into 4 groups according to their psychiatric diagnosis (schizophrenic psychosis, mood disorders, personality disorders, acute stress reaction) and each diagnostic group into three subgroups according to length of stay (T1< 7 days, T2 = 7–14 days, T3> 14 days). The subjective well-being indicators (subscales SWN: emotional regulation; self-control; mental functioning; social integration and physical functioning) and the severity of illness (CGI-S) were evaluated at admission and discharge.

Results

At discharge there is a statistically significant difference in the SWN subgroups among the four diagnostic groups except for social integration and total score with equal CGI-S scores. Schizophrenic patients and personality disorders show a subjective improvement at T2; mood disorders at T3; acute stress reactions T1 = T2. CGI shows a statistically improvement regardless of the length of stay.

Conclusions

Preliminary data suggest that SWN represents a predictor of clinical outcome and remission and together with the clinical evaluation it can help clinician to settle therapeutic programs.

Type
P03-596
Information
European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 1766
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.